Anzeige
Mehr »
Login
Donnerstag, 19.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Megachance: Aktien-Geheimtipp aus der 2. Reihe - der Markt schläft nicht!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 914178 | ISIN: US8688731004 | Ticker-Symbol: SU6
Frankfurt
18.12.24
08:12 Uhr
37,600 Euro
0,000
0,00 %
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
SURMODICS INC Chart 1 Jahr
5-Tage-Chart
SURMODICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
37,40039,20018.12.
37,60039,00018.12.

Aktuelle News zur SURMODICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.11.SURMODICS INC - 10-K, Annual Report-
07.11.Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down-
06.11.Surmodics Non-GAAP EPS of -$0.13 beats by $0.16, revenue of $33.2M beats by $2.8M2
06.11.Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results67EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial...
► Artikel lesen
06.11.SURMODICS INC - 8-K, Current Report-
30.10.Surmodics reports high success in limb ischemia study2
02.10.SRDX Stock Down Despite FDA Clearance for Pounce XL System3
01.10.FDA clears Surmodics' Pounce XL thrombectomy system3
SURMODICS Aktie jetzt für 0€ handeln
01.10.Surmodics receives FDA clearance for its thrombectomy system1
01.10.FDA clears Surmodics' expanded thrombectomy system1
14.08.Surmodics shareholders approve merger with BCE Parent2
13.08.Surmodics merger deal draws FTC second request1
08.08.SURMODICS INC - 8-K, Current Report1
31.07.Surmodics beats top-line and bottom-line estimates; suspends annual guidance1
31.07.SURMODICS INC - 10-Q, Quarterly Report2
31.07.SURMODICS INC - 8-K, Current Report1
31.07.Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results127EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial...
► Artikel lesen
29.05.Pre-market Movers: Cheche Group, AERWINS Technologies, Siyata Mobile, Surmodics, Ikena Oncology551CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheche Group Inc. (CCG) is up over 58% at $2.11. Siyata...
► Artikel lesen
29.05.Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million81EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it has entered...
► Artikel lesen
01.05.Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance149EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial...
► Artikel lesen
Seite:  Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1